Patent Strengthens Nexalin’s Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids,...
BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), ”), a clinical-stage biotechnology...
Funding from OneOhio Recovery Foundation will drive technology-enabled recovery services and increase access to critical support for Ohioans impacted by...
Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"...
This collaboration aims to give parents and families the tools and resources they need to live safe, balanced online lives....
FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for...
BOSTON, Feb. 24, 2025 /PRNewswire/ -- Q2i, a leader in digital innovation, has announced that its contingency management division (CMI)...
DENVER, Feb. 20, 2025 /PRNewswire/ -- SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), the leader in next-generation alcohol detection technology, and Orbiit, an...
New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders...
Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM. AUSTIN, Texas,...
Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 nicotinic...
West end Toronto emergency department is 40% larger, fully donor-fundedTORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- St. Joseph’s Health Centre...
SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical...
MIAMI, Feb. 10, 2025 /PRNewswire/ -- The Digital Safety Alliance (DSA) is proud to celebrate its one-year anniversary with the...
No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2...
HOUSTON--(BUSINESS WIRE)--Lightning Step, a leading provider of integrated CRM, EHR, and RCM solutions for behavioral health practices, has appointed Josh...
HOUSTON--(BUSINESS WIRE)--Lightning Step, a leading provider of integrated CRM, EHR, and RCM solutions for behavioral health practices, has appointed Josh...
Top Treatment Centers Across the USA: Vetted by Experts to Support Recovery Success BOSTON, Jan. 30, 2025 /PRNewswire/ -- TreatmentRehabCenters.org,...
Completion enables the End-of-Phase 2 (EOP2) interaction with the FDA on the design of the Phase 3 program and is...
In a polarized wellness market, we'll see both "analog wellness" (a great logging off and seizing of pre-digital experiences) and...